Lewes, DE -- (SBWire) -- 05/28/2019 --The Global Cancer Registry Software Market is accounted for $43.2 million in 2017 and is expected to reach $112.2 million by 2026 growing at a CAGR of 11.2% from 2017 to 2026. Some of the factors such as increase in prevalence of cancer and favorable government initiatives are impelling the market growth. However privacy and data security-related concerns are restricting the market growth. Increase in number of accountable care organizations is creating ample opportunities for the market growth.
Cancer Registry Software is a particular type of disease registry that is mainly used in order to establish and maintain a cancer incidence reporting system. The cancer registry system acts as an informational resource for the investigation of cancer and its causes. This type of registry is important as cancer is among the leading causes of death and therefore the collection of data on cancer cases from diagnosis through survivorship is beneficial in order to help identify trends and ultimately improve care for patients that are fighting cancer.
Based on type, the standalone software segment accounted for a larger share primarily due to the significant use of standalone software by government organizations & TPAs for population health management (due to its adaptability and interoperability). Also, standalone software provides practical and easy-to-use tools to store and process registry data, while standalone software customized for patient registries offers higher flexibility and features such as multiple system usage and automatic upgradation. Based on the geography, North America dominated the market growth due to the high burden of cancer, government funding initiatives to encourage the development of cancer registries.
Some of the key players in Cancer Registry Software market include, Onco, Inc., Rocky Mountain Cancer Data Systems, Mckesson Corporation, Elekta AB (PUB), C/Net Solutions and Electronic Registry Systems, Inc.
Types Covered:
- Integrated Software
- Standalone Software
Deployment Models Covered:
- Cloud-Based Models
- On-Premise Models
Database Types Covered:
- Commercial Databases
- Public Databases
Functionalities Covered:
- Patient Care Management
- Product Outcome Evaluation
- Cancer Reporting to Meet State and Federal Regulations
- Medical Research & Clinical Studies
End Users Covered:
- Hospitals & Medical Practices
- Government Organizations & Third-Party Administrators
- Pharmaceutical, Biotechnology, and Medical Device Companies
- Private Payers
- Research Centers
- Other End Users
Regions Covered:
- North America
US
Canada
Mexico
- Europe
Germany
UK
Italy
France
Spain
Rest of Europe
- Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
- South America
Argentina
Brazil
Chile
Rest of South America
- Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Spanning over 157 pages "Cancer Registry Software - Global Market Outlook (2017-2026)" report covers Executive Summary, Preface, Market Trend Analysis, Porters Five Force Analysis, Global Cancer Registry Software Market, By Type, Global Cancer Registry Software Market, By Deployment Model, Global Cancer Registry Software Market, By Database Type, Global Cancer Registry Software Market, By Functionality, Global Cancer Registry Software Market, By End User, Global Cancer Registry Software Market, By Geography, Key Developments, Company Profiling.
Please visit this link for more details: https://www.marketresearchreports.com/stratistics-mrc/cancer-registry-software-global-market-outlook-2017-2026
Find all Pharma and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare
For related reports please visit: https://www.marketresearchreports.com/search/site/Cancer
Read our Interactive Market Research Blog
About MarketResearchReports.com
MarketResearchReports.com is world's largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.
Contact us for your market research requirements: https://www.marketresearchreports.com/contact
Global Cancer Registry Software Market Is Grow at a CAGR of 11.2% and Expected to Reach USD 112.2 Million by 2026 from USD 43.2 Million in 2017